Johnson & Johnson
Mentioned in 37 analyzed podcast episodes across 10 shows
A major pharmaceutical and healthcare company discussed across business, health, and political podcasts for its innovation strategy, dividend profile, and competitive positioning in the GLP-1 market. Podcast mentions cover its vaccine development history (including a COVID vaccine withdrawn due to safety concerns), involvement in manufacturing contamination issues, and recent negotiations with the Trump administration on drug pricing and domestic manufacturing investments. The company has also been referenced in discussions of broader pharmaceutical industry practices, including pricing pressures from pharmacy benefit managers and corporate influence on health media coverage.
Mentioned On
Episode Mentions
WSJ Minute Briefing · Jul 28, 2026
Dow Rallies as Investors Rotate Out of Chip Stocks
“Drugmaker agreed to pay $5.5 billion to resolve remaining talc lawsuits, ending years of litigation”
Milk Road AI · Jul 20, 2026
Will AI Trade Stocks Better Than Us?
“Healthcare company mentioned as overlooked name that surged after being abandoned by AI-focused investors”
Bloomberg Intelligence · Jul 16, 2026
Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
“Medical devices business underperformed in recent earnings, creating drag on share price vs. Abbott's strength”
Pharma and BioTech Daily · Jul 16, 2026
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily
“Managing Stellaris patent expiration while Tremfaya generates over $2B quarterly sales to offset revenue decline”
Wall Street Breakfast · Jul 12, 2026
Earnings, inflation take center stage
“Reporting earnings Wednesday as part of broader earnings season calendar”
WSJ's Take On the Week · Jul 12, 2026
Are Corporate Earnings in a Bubble? This Quarter Is a Test
“Healthcare company reporting Q2 earnings; sector expected to show largest earnings decline year-over-year”
BioSpace · May 13, 2026
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
“CEO Joaquin Duato second highest paid at over $30M; largest healthcare company globally”
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Reported combination IBD therapy (finerenone + Symvepend) data that missed primary endpoint but advancing in refractory patients”
DGTL Voices with Ed Marx · May 7, 2026
See the Human Being First (ft. Phoebe Yang)
“CIO was guest speaker in Phoebe's Stanford AI class; discussed AI adoption strategy and IT professional development”
Pharma and BioTech Daily · May 7, 2026
Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily
“MedTech division reported successful clinical outcomes from Otava Surgical Robot System in gastric bypass surgeries”
CNBC's "Fast Money" · May 5, 2026
Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26
“Licensing partner for Protagonist's Icotide drug; commercializing psoriasis treatment with $10B peak sales projection”
Skin Anarchy · Apr 28, 2026
What “Efficacy” Actually Means in Skincare with Jack Jia of Musely
“Parent company of skincare brands, cited as example of big pharma unable to innovate in cosmetic dermatology”
Pharma and BioTech Daily · Apr 24, 2026
Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily
“Partnered with Viz.ai to enhance diagnostic precision in neurovascular applications using AI technology”
Mad Money w/ Jim Cramer · Apr 23, 2026
Mad Money w/ Jim Cramer 4/23/26
“Pharmaceutical company with AAA balance sheet and best pipeline of blockbusters; trading under 20x earnings”
The a16z Show · Apr 23, 2026
Martin Shkreli on AI, Pharma, and What Actually Matters
“Used as example of company more stable than sovereign nations; diversified healthcare portfolio across pharma, med tech, consumer health”
Wall Street Breakfast · Apr 23, 2026
ServiceNow tanks on margins
“Holding annual shareholder meeting with votes on safer pay and independent board chair proposals”
The iDesign Lab Podcast | Where Design, Business, and Culture Shape How We Live and Build · Apr 23, 2026
How Virtual Interior Design Is Making Luxury Spaces More Accessible, Scalable, and Client-Driven
“Large corporation where Christy worked in medical sales and marketing for 20-25 years before launching design business”
The Dr. Hyman Show · Apr 20, 2026
Can’t Fall or Stay Asleep? Your Sleep Questions Answered
“Referenced for their baby bath product containing lavender, cited as evidence that lavender lowers cortisol”
The Rich Roll Podcast · Apr 20, 2026
In Waves & War: Marcus & Amber Capone On Psychedelic Treatment For Veteran PTSD, Rebuilding Life After War & The Mission To Heal A Generation
“Pharmaceutical company entering psychedelic market after startup validation and Phase 2 clinical success”
Morning Brew Daily · Apr 13, 2026
US Plans Hormuz Blockade & Wall Street Bigwigs Nervous About Mythos
“Reporting Q1 earnings this week as part of earnings season coverage”
Mad Money w/ Jim Cramer · Apr 10, 2026
Mad Money w/ Jim Cramer 4/10/26
“Cramer's favorite pharma stock; transformed company with strong pipeline; typically rallies post-earnings call”
A Beginner's Guide to AI · Apr 1, 2026
How to Invest in AI Without Getting Fooled by Hype, with Talullah Le Merle
“Named as FTSE 100 client during speaker's consulting work on digital transformation”
Global News Podcast · Mar 10, 2026
Hegseth: Today ‘most intense’ day of US strikes on Iran
“Named in major UK class action lawsuit, exemplifying rising litigation exposure for multinational corporations”
Adam Carolla Show · Mar 3, 2026
Why the Government Lied about COVID w/ Gavin de Becker
“Baby powder manufacturer that disclosed asbestos content to FDA in 1980s but wasn't forced to eliminate it until 2023”
Motley Fool Money · Feb 22, 2026
How to Spot Winning Innovation
“Mentioned as Fortune 500 company that Lorraine Marchand has advised on innovation strategy”
Mad Money w/ Jim Cramer · Feb 5, 2026
Mad Money w/ Jim Cramer 2/4/26
“Solid pharma earner with strong dividend and buyback profile; competing in GLP-1 space”
Therapist Uncensored Podcast · Feb 3, 2026
Nontoxic Guide to Healthy Living with Dr. Aly Cohen (290)
“Referenced as corporate sponsor influencing media coverage of environmental health research”
Congressional Dish · Jan 31, 2026
CD331: December 2025 — Authorizing Future Disasters
“Produced contaminated vaccine doses from Emergent BioSolutions contract overseen by Robert Kadlec”
Leaked · Jan 27, 2026
Redfield on Risk: Gain-of-Function, Bird Flu, and the Next Pandemic
“COVID vaccine developer; vaccine withdrawn from market due to blood clot side effects”
The Al Franken Podcast · Jan 25, 2026
Wendell Potter on The Healthcare Crisis
“Pharmaceutical company subject to PBM rebate demands; example of drug maker forced to pay kickbacks to PBMs for formulary placement”
The Rest Is History · Jan 22, 2026
637. Revolution in Iran: Rise of the Ayatollah (Part 2)
“Had factories and investments in Iran facing losses due to revolution”
Squawk Pod · Jan 9, 2026
Internet Blackout in Iran & Protests in Minneapolis 1/9/26
“Reached deal with Trump administration to cut drug prices in exchange for tariff exemptions; announced $55B U.S. investment including two new manufacturing facilities”
The Dylan Gemelli Podcast · Dec 29, 2025
Episode #76 Featuring Shanna Pearson! A MASTERCLASS on ADHD! Impact of ADHD on life and relationships, Misdiagnosis of ADHD, ADHD vs. Anxiety, Recognizing ADHD signs and more!
“Named as world-class institution receiving Shanna's executive coaching services”
The Vault Unlocked · Nov 5, 2025
The $25 Billion Infomercial Empire Story
“Trudeau exposed talcum powder cancer risks in baby powder 20+ years before product was banned from market”
Starter Story · Sep 26, 2025
I Became A Venture Capitalist With Only $1,000 | Starter Story
“Alex's first post-college employer where he worked in medical device sales before transitioning to startups”
The Code To Winning · Sep 6, 2025
BLUEPRINT TO BUILDING A 9 FIGURE BUSINESS || JAMIL FRAZIER || EPISODE 054
“Jamil's first corporate job in pharmaceutical sales before launching his entrepreneurial journey”
Proven Podcast · Aug 20, 2025
The Most Expensive Mistake Money Can't Fix - Kevin Trudeau
“Removed talcum powder (baby powder) from market after Trudeau's earlier warnings proved accurate”